miR-155 has been identified as an oncogene in various types of cancers. Its overexpression is frequently observed in malignancies such as breast cancer, lung cancer, lymphoma, and leukemia. Elevated levels of miR-155 contribute to cancer progression by promoting cell proliferation, inhibiting apoptosis, and enhancing metastasis.
